With reference to the news appeared in CNBC TV 18 & moneycontrol.com, March 15, 2016 – ‘US FDA cited 9 observations in Goa inspection last week’, Lupin has submitted a copy of clarification.
The above information is a part of company’s filings submitted to BSE.